HRSA Delays 340B Drug Discount Rule

The Health Resources and Services Administration has delayed the compliance date for a rule prohibiting certain hospitals participating in the 340B drug discount pricing program from purchasing outpatient drugs through group purchasing organizations, according to an AHA News Now report.

Advertisement

The rule, affecting disproportionate share hospitals, children’s hospitals and free-standing cancer hospitals, has a new compliance date of August 7, 2013 (originally April 7, 2013). No extensions will be granted beyond August 7.  

A delay had been requested by the AHA and 340B hospital members, to allow for more time to work with vendors and update inventory management systems.

More Articles on 340B Programs:

AHA Wants to Delay Rule Prohibiting Some Hospitals From Obtaining Drugs Through GPOs
Sen. Grassley Targets Duke, UNC, Carolinas Hospitals for Use of Discount Drug Program
Is Your 340B Program Prepared for an Audit?  

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.